176 related articles for article (PubMed ID: 25142793)
1. DNMTs as potential therapeutic targets in high-risk pediatric embryonal brain tumors.
Sin-Chan P; Huang A
Expert Opin Ther Targets; 2014 Oct; 18(10):1103-7. PubMed ID: 25142793
[TBL] [Abstract][Full Text] [Related]
2. Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR.
Kleinman CL; Gerges N; Papillon-Cavanagh S; Sin-Chan P; Pramatarova A; Quang DA; Adoue V; Busche S; Caron M; Djambazian H; Bemmo A; Fontebasso AM; Spence T; Schwartzentruber J; Albrecht S; Hauser P; Garami M; Klekner A; Bognar L; Montes JL; Staffa A; Montpetit A; Berube P; Zakrzewska M; Zakrzewski K; Liberski PP; Dong Z; Siegel PM; Duchaine T; Perotti C; Fleming A; Faury D; Remke M; Gallo M; Dirks P; Taylor MD; Sladek R; Pastinen T; Chan JA; Huang A; Majewski J; Jabado N
Nat Genet; 2014 Jan; 46(1):39-44. PubMed ID: 24316981
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic mechanisms regulating neural development and pediatric brain tumor formation.
Faria CM; Rutka JT; Smith C; Kongkham P
J Neurosurg Pediatr; 2011 Aug; 8(2):119-32. PubMed ID: 21806352
[TBL] [Abstract][Full Text] [Related]
4. Molecular Classification and Management of Rare Pediatric Embryonal Brain Tumors.
Sin-Chan P; Li BK; Ho B; Fonseca A; Huang A
Curr Oncol Rep; 2018 Jul; 20(9):69. PubMed ID: 29995179
[TBL] [Abstract][Full Text] [Related]
5. Global DNA methylation analysis reveals miR-214-3p contributes to cisplatin resistance in pediatric intracranial nongerminomatous malignant germ cell tumors.
Hsieh TH; Liu YR; Chang TY; Liang ML; Chen HH; Wang HW; Yen Y; Wong TT
Neuro Oncol; 2018 Mar; 20(4):519-530. PubMed ID: 29036598
[TBL] [Abstract][Full Text] [Related]
6. MEK Inhibitors Reverse Growth of Embryonal Brain Tumors Derived from Oligoneural Precursor Cells.
Modzelewska K; Boer EF; Mosbruger TL; Picard D; Anderson D; Miles RR; Kroll M; Oslund W; Pysher TJ; Schiffman JD; Jensen R; Jette CA; Huang A; Stewart RA
Cell Rep; 2016 Oct; 17(5):1255-1264. PubMed ID: 27783941
[TBL] [Abstract][Full Text] [Related]
7. [Recent advances in molecular biology of central nervous system embryonal tumors and development of potential molecular targeted therapies].
Roszkowski M; Grajkowska W
Neurol Neurochir Pol; 2006; 40(3):212-8. PubMed ID: 16794961
[TBL] [Abstract][Full Text] [Related]
8. Expression pattern of DNA-methyltransferases and its health implication (short review).
Kvaratskhelia E; Tkemaladze T; Abzianidze E
Georgian Med News; 2014 Mar; (228):76-81. PubMed ID: 24743128
[TBL] [Abstract][Full Text] [Related]
9. CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity.
Spence T; Sin-Chan P; Picard D; Barszczyk M; Hoss K; Lu M; Kim SK; Ra YS; Nakamura H; Fangusaro J; Hwang E; Kiehna E; Toledano H; Wang Y; Shi Q; Johnston D; Michaud J; La Spina M; Buccoliero AM; Adamek D; Camelo-Piragua S; Peter Collins V; Jones C; Kabbara N; Jurdi N; Varlet P; Perry A; Scharnhorst D; Fan X; Muraszko KM; Eberhart CG; Ng HK; Gururangan S; Van Meter T; Remke M; Lafay-Cousin L; Chan JA; Sirachainan N; Pomeroy SL; Clifford SC; Gajjar A; Shago M; Halliday W; Taylor MD; Grundy R; Lau CC; Phillips J; Bouffet E; Dirks PB; Hawkins CE; Huang A
Acta Neuropathol; 2014 Aug; 128(2):291-303. PubMed ID: 24839957
[TBL] [Abstract][Full Text] [Related]
10. Deregulated chromatin remodeling in the pathobiology of brain tumors.
Spyropoulou A; Piperi C; Adamopoulos C; Papavassiliou AG
Neuromolecular Med; 2013 Mar; 15(1):1-24. PubMed ID: 23114751
[TBL] [Abstract][Full Text] [Related]
11. Embryonal tumor with multilayered rosettes,
Tauziède-Espariat A; Dufour C; Zerah M; Gareton A; Dangouloff-Ros V; Lechapt E; Boddaert N; Varlet P
Clin Neuropathol; 2021; 40(1):11-16. PubMed ID: 32831158
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic cancer therapy: Proof of concept and remaining challenges.
Mund C; Lyko F
Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics and cancer treatment.
Kristensen LS; Nielsen HM; Hansen LL
Eur J Pharmacol; 2009 Dec; 625(1-3):131-42. PubMed ID: 19836388
[TBL] [Abstract][Full Text] [Related]
14. A developmental program drives aggressive embryonal brain tumors.
Archer TC; Pomeroy SL
Nat Genet; 2014 Jan; 46(1):2-3. PubMed ID: 24370739
[TBL] [Abstract][Full Text] [Related]
15. Embryonal tumors with multi-layered rosettes: a disease of dysregulated miRNAs.
Raghuram N; Khan S; Mumal I; Bouffet E; Huang A
J Neurooncol; 2020 Oct; 150(1):63-73. PubMed ID: 33090313
[TBL] [Abstract][Full Text] [Related]
16. Targeting epigenetic regulators for cancer therapy.
Wee S; Dhanak D; Li H; Armstrong SA; Copeland RA; Sims R; Baylin SB; Liu XS; Schweizer L
Ann N Y Acad Sci; 2014 Feb; 1309():30-6. PubMed ID: 24571255
[TBL] [Abstract][Full Text] [Related]
17. Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity.
Korshunov A; Sturm D; Ryzhova M; Hovestadt V; Gessi M; Jones DT; Remke M; Northcott P; Perry A; Picard D; Rosenblum M; Antonelli M; Aronica E; Schüller U; Hasselblatt M; Woehrer A; Zheludkova O; Kumirova E; Puget S; Taylor MD; Giangaspero F; Peter Collins V; von Deimling A; Lichter P; Huang A; Pietsch T; Pfister SM; Kool M
Acta Neuropathol; 2014 Aug; 128(2):279-89. PubMed ID: 24337497
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood.
Mühlisch J; Schwering A; Grotzer M; Vince GH; Roggendorf W; Hagemann C; Sörensen N; Rickert CH; Osada N; Jürgens H; Frühwald MC
Oncogene; 2006 Feb; 25(7):1111-7. PubMed ID: 16186793
[TBL] [Abstract][Full Text] [Related]
19. Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma.
Kim TY; Zhong S; Fields CR; Kim JH; Robertson KD
Cancer Res; 2006 Aug; 66(15):7490-501. PubMed ID: 16885346
[TBL] [Abstract][Full Text] [Related]
20. Vorinostat, SAHA, represses telomerase activity via epigenetic regulation of telomerase reverse transcriptase in non-small cell lung cancer cells.
Li CT; Hsiao YM; Wu TC; Lin YW; Yeh KT; Ko JL
J Cell Biochem; 2011 Oct; 112(10):3044-53. PubMed ID: 21678477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
